The aim of the present work was to produce a cationic solid lipid nanoparticle (SLN) as non-viral vector for protein delivery. Cationic SLN were produced by double emulsion method, composed of softisan® 100, cetyltrimethylammonium bromide (CTAB), Tween® 80, Span® 80, glycerol and lipoid® S75 loading insulin as model protein. The formulation was characterized in terms of mean hydrodynamic diameter (z-ave), polydispersity index (PI), zeta potential (ZP), stability during storage time, stability after lyophilization, effect of toxicity and transfection ability in HeLa cells, in vitro release profile and morphology. SLN were stable for 30 days and showed minimal changes in their physicochemical properties after lyophilization. The particles exhibited a relatively slow release, spherical morphology and were able to transfect HeLa cells, but toxicity remained an obstacle. Results suggest that SLN are nevertheless promising for delivery of proteins or nucleic acids for gene therapy.66 7882Boulaiz, H., Marchal, J.A., Prados, J., Melguizo, C., Aranega, A., Non-viral and viral vectors for gene therapy (2005) Cell. Mol. Biol. (Noisy-le-grand), 51, pp. 3-22Bozelli, J.C., Jr., Sasahara, E.T., Pinto, M.R., Nakaie, C.R., Schreier, S., Effect of head group and curvature on binding of the antimicrobial peptide tritrpticin to lipid membranes (2012) Chem. Phys. Lipids, 165, pp. 365-373Bradford, M.M., Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254Brgles, M., Santak, M., Halassy, B., Forcic, D., Tomasic, J., Influence of charge ratio of liposome/DNA complexes on their size after extrusion and transfection efficiency (2012) Int. J. Nanomed., 7, pp. 393-401Carbone, C., Tomasello, B., Ruozi, B., Renis, M., Puglisi, G., Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design (2012) Eur. J. Med. Chem., 49, pp. 110-117Carbone, C., Campisi, A., Manno, D., Serra, A., Spatuzza, M., Musumeci, T., Bonfanti, R., Puglisi, G., The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC (2014) Colloids Surf. B Biointerfaces, 121, pp. 1-10Carbone, C., Campisi, A., Musumeci, T., Raciti, G., Bonfanti, R., Puglisi, G., FA-loaded lipid drug delivery systems: Preparation, characterization and biological studies (2014) Eur. J. Pharm. Sci., 52, pp. 12-20Choi, W.J., Kim, J.K., Choi, S.H., Park, J.S., Ahn, W.S., Kim, C.K., Low toxicity of cationic lipid-based emulsion for gene transfer (2004) Biomaterials, 25, pp. 5893-5903Choi, S.H., Jin, S.E., Lee, M.K., Lim, S.J., Park, J.S., Kim, B.G., Ahn, W.S., Kim, C.K., Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells (2008) Eur. J. Pharm. Biopharm., 68, pp. 545-554Cortesi, R., Bergamini, P., Ravani, L., Drechsler, M., Costenaro, A., Pinotti, M., Campioni, M., Esposito, E., Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors (2012) Int. J. Pharm., 431, pp. 176-182Del Pozo-Rodriguez, A., Delgado, D., Solinis, M.A., Gascon, A.R., Pedraz, J.L., Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity (2007) Int. J. Pharm., 339, pp. 261-268Doktorovova, S., Shegokar, R., Rakovsky, E., Gonzalez-Mira, E., Lopes, C.M., Silva, A.M., Martins-Lopes, P., Souto, E.B., Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies (2011) Int. J. Pharm., 420, pp. 341-349Doktorovova, S., Shegokar, R., Martins-Lopes, P., Silva, A.M., Lopes, C.M., Muller, R.H., Souto, E.B., Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN) (2012) Eur. J. Pharm. Sci., 45, pp. 606-612Fangueiro, J.F., Andreani, T., Egea, M.A., Garcia, M.L., Souto, S.B., Silva, A.M., Souto, E.B., Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity (2014) Int. J. Pharm., 461, pp. 64-73Griffin, W.C., Classification of surface active agents by HLB (1949) J. Soc. Cosmet. Chem., 1, pp. 311-326Griffin, W.C., Calculation of HLB valuess of nonionic surfactants (1954) J. Soc. Cosmet. Chem., 5, pp. 249-256Howard, M.D., Lu, X., Jay, M., Dziubla, T.D., Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles (2012) Drug Dev. Ind. Pharm.Hwang, T.L., Sung, C.T., Aljuffali, I.A., Chang, Y.T., Fang, J.Y., Cationic surfactants in the form of nanoparticles and micelles elicit different human neutrophil responses: A toxicological study (2014) Colloids Surf. B Biointerfaces, 114, pp. 334-341Jiang, Z., Sun, C., Yin, Z., Zhou, F., Ge, L., Liu, X., Kong, F., Comparison of two kinds of nanomedicine for targeted gene therapy: Premodified or postmodified gene delivery systems (2012) Int. J. Nanomed., 7, pp. 2019-2031Juillerat-Jeanneret, L., Schmitt, F., Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: Looking for the grail (2007) Med. Res. Rev., 27, pp. 574-590Liu, C.H., Yu, S.Y., Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery (2010) Colloids Surf. B Biointerfaces, 79, pp. 509-515Liu, C.H., Yu, S.Y., Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery (2012) Colloids Surf. B Biointerfaces, 79, pp. 509-515Liu, Z., Zhong, Z., Peng, G., Wang, S., Du, X., Yan, D., Zhang, Z., Liu, J., Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles (2009) Drug Deliv., 16, pp. 341-347Olbrich, C., Bakowsky, U., Lehr, C.M., Muller, R.H., Kneuer, C., Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA (2001) J. Control Release, 77, pp. 345-355Radomska-Soukharev, A., Stability of lipid excipients in solid lipid nanoparticles (2007) Adv. Drug Deliv. Rev., 59, pp. 411-418Rudolph, C., Rosenecker, J., Formation of solid lipid nanoparticle (sln)-gene vector complexe for transfection of mammalian cells in vitro (2012) Cold Spring Harb Protoc, 2012 (3), pp. 357-360Severino, P., Souto, E.B., Pinho, S.C., Santana, M.H., Hydrophilic coating of mitotane-loaded lipid nanoparticles: Preliminary studies for mucosal adhesion (2013) Pharm. Dev. Technol., 18 (3), pp. 577-581. , Epub 2011 Sep 29Severino, P., Santana, M.H., Souto, E.B., Optimizing SLN and NLC by 22 full factorial design: Effect of homogenization technique (2012) Mater. Sci. Eng. C, 32, pp. 1375-1379Siddiqui, A., Gupta, V., Liu, Y.Y., Nazzal, S., Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES) (2012) Int. J. Pharm., 431, pp. 222-229Siddiqui, A., Alayoubi, A., Nazzal, S., The effect of emulsifying wax on the physical properties of CTAB-based solid lipid nanoparticles (SLN) (2014) Pharm. Dev. Technol., 19, pp. 125-128Simberg, D., Weisman, S., Talmon, Y., Barenholz, Y., DOTAP (and other cationic lipids): Chemistry, biophysics, and transfection (2004) Crit. Rev. Ther. Drug Carrier Syst., 21, pp. 257-317Tabatt, K., Sameti, M., Olbrich, C., Muller, R.H., Lehr, C.M., Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer (2004) Eur. J. Pharm. Biopharm., 57, pp. 155-162Tabatt, K., Sameti, M., Olbrich, C., Muller, R.H., Lehr, C.M., Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer (2004) Eur. J. Pharm. Biopharm., 57, pp. 155-162Taveira, S.F., Araujo, L.M., De Santana, D.C., Nomizo, A., De Freitas, L.A., Lopez, R.F., Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin (2012) J. Biomed. Nanotechnol., 8, pp. 219-228Toledo, M.A., Janissen, R., Favaro, M.T., Cotta, M.A., Monteiro, G.A., Prazeres, D.M., Souza, A.P., Azzoni, A.R., Development of a recombinant fusion protein based on the dynein light chain LC8 for non-viral gene delivery (2012) J. Control Release, 159, pp. 222-231Torchilin, V.P., Multifunctional nanocarriers (2006) Adv. Drug Deliv. Rev., 58, pp. 1532-1555Vighi, E., Ruozi, B., Montanari, M., Battini, R., Leo, E., PDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles (2010) Int. J. Pharm., 389, pp. 254-261Vighi, E., Montanari, M., Ruozi, B., Iannuccelli, V., Leo, E., The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier (2012) Drug Deliv., 19, pp. 1-10Wang, Y., Zhu, L., Dong, Z., Xie, S., Chen, X., Lu, M., Wang, X., Zhou, W., Preparation and stability study of norfloxacin-loaded solid lipid nanoparticle suspensions (2012) Colloids Surf. B Biointerfaces, 98, pp. 105-111Yang, T., Sheng, H.H., Feng, N.P., Wei, H., Wang, Z.T., Wang, C.H., Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: Characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity (2013) J. Pharm. Sci., 102, pp. 4414-4425Yu, W., Liu, C., Ye, J., Zou, W., Zhang, N., Xu, W., Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery (2009) Nanotechnology, 20, p. 215102